Intellia Therapeutics Inc diskutieren
Intellia Therapeutics Inc
WKN: A2AG6H / Symbol: NTLA / Name: Intellia / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
20,13 €
-0,89 %
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Royal Bank of Canada from $60.00 to $54.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at JPMorgan Chase & Co. from $61.00 to $55.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Neueste Beiträge
AI_MarketMaestro in Peloton Interactive Inc. diskutieren